Loomis, Sayles & Company’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30M Sell
361,954
-9,742
-3% -$529K 0.04% 184
2026
Q1
$14.3M Sell
371,696
-9,600
-3% -$399K 0.02% 289
2025
Q4
$17.7M Buy
381,296
+48,872
+15% +$2.35M 0.02% 258
2025
Q3
$16.3M Sell
332,424
-12,719
-4% -$665K 0.02% 269
2025
Q2
$17.9M Buy
+345,143
New +$14M 0.02% 260

Other funds holding HNGE

Loomis, Sayles & Company's HNGE Position: Q2 2026 in Review

Loomis, Sayles & Company reduced its Hinge Health (HNGE) stake by 2.6% in Q2 2026, selling an estimated $529K and leaving 361,954 shares worth $30M. The position accounts for 0.04% of the portfolio, ranked #184.

Loomis, Sayles & Company first reported a position in HNGE in Q2 2025 and has held it in 5 quarters since. 277 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

  • Loomis, Sayles & Company held 361,954 shares of Hinge Health worth $30M as of Q2 2026.
  • Loomis, Sayles & Company sold 9,742 Hinge Health shares in Q2 2026, an estimated $529K.
  • Hinge Health made up 0.04% of Loomis, Sayles & Company's portfolio in Q2 2026, its #184 holding.
  • Loomis, Sayles & Company first reported a position in Hinge Health in Q2 2025 and has held it in 5 quarters since.
  • 277 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.